We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of MR Enteroclysis and MRI With Per Oral Contrast Using a 6 % Mannitol Solution.

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2006 by University of Oslo.
Recruitment status was:  Active, not recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00204165
First Posted: September 20, 2005
Last Update Posted: September 11, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University of Oslo
  Purpose
The purpose of this study is to compare MRI enteroclysis with MRI of the small bowel with a per oral 6%mannitol solution.Our hypothesis is that the peroral technique preform the same way as MRI Enteroclysis.

Condition Intervention Phase
Magnetic Resonance Imaging, Intestine Small, Crohn Disease. Procedure: MRI of the small bowel Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: MRI of the Small Bowel. Comparison of Different Techniques and Contrast.

Resource links provided by NLM:


Further study details as provided by University of Oslo:

Estimated Enrollment: 40
Study Start Date: November 2004
Estimated Study Completion Date: June 2005
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • above 18 years
  • known Crohns disease or strong suspicion.
  • need of a small bowel examination

Exclusion Criteria:

  • pregnant
  • electrolyte disturbances.
  • Any MRI contraindications.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00204165


Locations
Norway
Ulleval Universitets sykehus
Kirkeveien 166, Oslo, Norway, 0407
Sponsors and Collaborators
University of Oslo
Investigators
Study Director: Nils-Einar Kløw, Prof. MD Ulleval Universitetssykehus
  More Information

ClinicalTrials.gov Identifier: NCT00204165     History of Changes
Other Study ID Numbers: 431-04150
First Submitted: September 13, 2005
First Posted: September 20, 2005
Last Update Posted: September 11, 2006
Last Verified: September 2006

Additional relevant MeSH terms:
Crohn Disease
Inflammatory Bowel Diseases
Gastroenteritis
Gastrointestinal Diseases
Digestive System Diseases
Intestinal Diseases


To Top